vs

Side-by-side financial comparison of Allison Transmission Holdings Inc (ALSN) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $737.0M, roughly 1.7× Allison Transmission Holdings Inc). Dexcom runs the higher net margin — 21.2% vs 13.4%, a 7.8% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -7.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -3.4%).

Allison Transmission Holdings Inc. is an American manufacturer of commercial duty automatic transmissions and hybrid propulsion systems. Allison products are specified by over 250 vehicle manufacturers and are used in many market sectors, including bus, refuse, fire, construction, distribution, military, and specialty applications.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

ALSN vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.7× larger
DXCM
$1.3B
$737.0M
ALSN
Growing faster (revenue YoY)
DXCM
DXCM
+29.0% gap
DXCM
21.6%
-7.4%
ALSN
Higher net margin
DXCM
DXCM
7.8% more per $
DXCM
21.2%
13.4%
ALSN
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-3.4%
ALSN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALSN
ALSN
DXCM
DXCM
Revenue
$737.0M
$1.3B
Net Profit
$99.0M
$267.3M
Gross Margin
48.0%
62.9%
Operating Margin
23.2%
25.6%
Net Margin
13.4%
21.2%
Revenue YoY
-7.4%
21.6%
Net Profit YoY
-43.4%
153.6%
EPS (diluted)
$1.18
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALSN
ALSN
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$737.0M
$1.3B
Q3 25
$693.0M
$1.2B
Q2 25
$814.0M
$1.2B
Q1 25
$766.0M
$1.0B
Q4 24
$796.0M
$1.1B
Q3 24
$824.0M
$994.2M
Q2 24
$816.0M
$1.0B
Net Profit
ALSN
ALSN
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$99.0M
$267.3M
Q3 25
$137.0M
$283.8M
Q2 25
$195.0M
$179.8M
Q1 25
$192.0M
$105.4M
Q4 24
$175.0M
$151.7M
Q3 24
$200.0M
$134.6M
Q2 24
$187.0M
$143.5M
Gross Margin
ALSN
ALSN
DXCM
DXCM
Q1 26
62.9%
Q4 25
48.0%
62.9%
Q3 25
47.5%
60.5%
Q2 25
49.4%
59.5%
Q1 25
49.3%
56.9%
Q4 24
46.9%
58.9%
Q3 24
48.1%
59.7%
Q2 24
48.3%
62.4%
Operating Margin
ALSN
ALSN
DXCM
DXCM
Q1 26
25.6%
Q4 25
23.2%
25.6%
Q3 25
29.4%
20.1%
Q2 25
31.4%
18.4%
Q1 25
32.5%
12.9%
Q4 24
29.5%
17.0%
Q3 24
31.6%
15.3%
Q2 24
32.2%
15.7%
Net Margin
ALSN
ALSN
DXCM
DXCM
Q1 26
21.2%
Q4 25
13.4%
21.2%
Q3 25
19.8%
23.5%
Q2 25
24.0%
15.5%
Q1 25
25.1%
10.2%
Q4 24
22.0%
13.6%
Q3 24
24.3%
13.5%
Q2 24
22.9%
14.3%
EPS (diluted)
ALSN
ALSN
DXCM
DXCM
Q1 26
$0.67
Q4 25
$1.18
$0.67
Q3 25
$1.63
$0.70
Q2 25
$2.29
$0.45
Q1 25
$2.23
$0.27
Q4 24
$2.01
$0.37
Q3 24
$2.27
$0.34
Q2 24
$2.13
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALSN
ALSN
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$1.5B
$917.7M
Total DebtLower is stronger
$2.9B
Stockholders' EquityBook value
$1.9B
$2.7B
Total Assets
$6.1B
$6.3B
Debt / EquityLower = less leverage
1.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALSN
ALSN
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$1.5B
$917.7M
Q3 25
$902.0M
$1.8B
Q2 25
$778.0M
$1.2B
Q1 25
$753.0M
$904.9M
Q4 24
$781.0M
$606.1M
Q3 24
$788.0M
$621.2M
Q2 24
$648.0M
$939.2M
Total Debt
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
$2.9B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.4B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
ALSN
ALSN
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$1.9B
$2.7B
Q3 25
$1.8B
$2.7B
Q2 25
$1.8B
$2.6B
Q1 25
$1.7B
$2.3B
Q4 24
$1.7B
$2.1B
Q3 24
$1.6B
$2.0B
Q2 24
$1.5B
$2.4B
Total Assets
ALSN
ALSN
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$6.1B
$6.3B
Q3 25
$5.5B
$7.5B
Q2 25
$5.4B
$7.3B
Q1 25
$5.4B
$6.8B
Q4 24
$5.3B
$6.5B
Q3 24
$5.4B
$6.4B
Q2 24
$5.2B
$6.8B
Debt / Equity
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
1.56×
Q3 25
1.31×
Q2 25
1.38×
Q1 25
1.45×
Q4 24
1.46×
Q3 24
1.49×
Q2 24
1.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALSN
ALSN
DXCM
DXCM
Operating Cash FlowLast quarter
$243.0M
Free Cash FlowOCF − Capex
$169.0M
FCF MarginFCF / Revenue
22.9%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
2.45×
TTM Free Cash FlowTrailing 4 quarters
$661.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
$243.0M
$294.0M
Q3 25
$228.0M
$659.9M
Q2 25
$184.0M
$303.0M
Q1 25
$181.0M
$183.8M
Q4 24
$211.0M
$301.4M
Q3 24
$246.0M
$199.5M
Q2 24
$171.0M
$279.4M
Free Cash Flow
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
$169.0M
$192.1M
Q3 25
$184.0M
$579.4M
Q2 25
$153.0M
$208.9M
Q1 25
$155.0M
$96.8M
Q4 24
$136.0M
$176.8M
Q3 24
$210.0M
$88.3M
Q2 24
$150.0M
$213.3M
FCF Margin
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
22.9%
15.3%
Q3 25
26.6%
47.9%
Q2 25
18.8%
18.1%
Q1 25
20.2%
9.3%
Q4 24
17.1%
15.9%
Q3 24
25.5%
8.9%
Q2 24
18.4%
21.2%
Capex Intensity
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
10.0%
8.1%
Q3 25
6.3%
6.7%
Q2 25
3.8%
8.1%
Q1 25
3.4%
8.4%
Q4 24
9.4%
11.2%
Q3 24
4.4%
11.2%
Q2 24
2.6%
6.6%
Cash Conversion
ALSN
ALSN
DXCM
DXCM
Q1 26
Q4 25
2.45×
1.10×
Q3 25
1.66×
2.33×
Q2 25
0.94×
1.69×
Q1 25
0.94×
1.74×
Q4 24
1.21×
1.99×
Q3 24
1.23×
1.48×
Q2 24
0.91×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALSN
ALSN

North America On Highway$361.0M49%
Service Parts Support Equipment And Other$160.0M22%
Outside North America On Highway$131.0M18%
Defense$73.0M10%
Global Off-Highway$12.0M2%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons